Skip to content

Effects of Postconditioning On Myocardial Reperfusion

Effects of Postconditioning On Myocardial Reperfusion in Patients With ST-segment Elevation Myocardial Infarction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00942500
Acronym
POST
Enrollment
700
Registered
2009-07-21
Start date
2009-07-31
Completion date
2012-08-31
Last updated
2012-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction, Myocardial Reperfusion

Keywords

Post-conditioning, ST-elevation myocardial infarction, Angioplasty, Transluminal, Percutaneous Coronary

Brief summary

The purpose of this study is to investigate the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction.

Interventions

Coronary angiogram is performed to allow identification of the culprit coronary artery and to check no reperfusion before PCI (TIMI grade \<2). Restoration of coronary blood flow can be achieved by thrombus aspiration, balloon angioplasty, direct stenting or together.In the postconditioning group, immediately after restoration (TIMI grade ≥2) of coronary flow (without regard to method of achieving restoration), angioplasty balloon will be positioned at the culprit lesion or stented segment and inflated 4 times for 1 minute with low-pressure (4 to 6 atm) inflations, each separated by 1 minute of reflow. When restoration of coronary flow is achieved by thrombus aspiration or balloon angioplasty and residual stenosis is remained ≥30%, stent will be deployed.

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

General Inclusion Criteria * Subject must be at least 18 years of age. * Subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of receiving postconditioning and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure * Diagnosis of STEMI 1. presence of chest pain for more than 30 minutes but less than 12 hours after symptom onset 2. ST-segment elevation more than 1 mm in at least 2 contiguous leads Angiographic Inclusion Criteria * Target lesion(s) must be located in a native coronary artery * Target lesion(s) must be amenable for percutaneous coronary intervention * TIMI flow grade of infarct related arteries \<2 General

Exclusion criteria

* Patients with hemodynamic instability or those with cardiogenic shock * Target lesion is located in left main stem * Rescue PCI after thrombolysis or facilitated PCI * Non-cardiac co-morbid conditions are present with life expectancy \<1 year or that may result in protocol non-compliance (per site investigator's medical judgment) * Female of childbearing potential, unless a recent pregnancy test is negative, who possibly plan to become pregnant any time after enrollment into this study

Design outcomes

Primary

MeasureTime frame
The dichotomous rate of complete ST-segment resolution (STR)at 30 minutes after final contrast injection

Secondary

MeasureTime frameDescription
Thrombolysis in Myocardial Infarction (TIMI) flow gradewithin 10 minutes after PCI
Angiographic no-reflowduring PCI
All deathat 30 days and 1 year
Stent thrombosisat 30 days and 1 year
Myocardial blush gradewithin 10 minutes after PCI
Myocardial infarctionat 30 days and 1 year
Severe heart failureat 30 days and 1 yearSevere heart failure was defined as heart failure with documented arterial partial pressure of oxygen less than 60 mmHg or with pulmonary edema documented radiographically or requiring intubation, 100% oxygen, or insertion of a mechanical support device.
Target vessel revascularization (TVR)at 30 days and 1 year
Composite of death, MI, severe heart failure, or stent thrombosisat 30 days and 1 year
Cardiac deathat 30 days and 1 year

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026